Fascia tissue network

Fascia Innovation — Investor Narrative 2026

The Global Shift
in Physical Relief

1.5 billion people suffer from chronic pain. The global cost: $635 billion annually. For decades, the answer has been pharmacological — painkillers that mask symptoms without addressing the root cause. The body deserves better.

1.5B
People with chronic pain
$635B
Annual economic cost
$6.8T
Global wellness market
$96B
Non-opioid pain market by 2034
Read the Full Story ↓

A Family's Mission

Built on Conviction,
Not Just Commerce

In 2010, Hans Bohlin saw what the established medical community was missing: that treating symptoms locally would never solve systemic physical problems. He understood that fascia — the body's connective tissue network — was the key to unlocking the body's natural ability to heal and function.

Hans was joined by his sons, Axel and Ivar, creating a multi-generational force. Axel brought strategic vision, digital scalability, and AI integration. Ivar focused on operational excellence and clinical execution. Together, they have built a structure designed to outlast them — a company driven by the mission to help people understand their bodies and achieve their full potential.

"This is not a tech startup looking for a quick exit. It is a deeply rooted movement, managed by a family acting as stewards of a new standard in human well-being."

Hans Bohlin — Founder

Hans Bohlin — Founder & Visionary

Axel & Ivar Bohlin

Axel & Ivar Bohlin — CEO & COO

The Proof

Why It Works

We do not make medical claims. We deliver functional results — validated by science and massive real-world data.

The Science

Fasciocytes & the Frozen Shoulder Study

In 2018, Dr. Carla Stecco identified fasciocytes — a new class of cells within the fascia that produce the hyaluronic acid necessary for tissue gliding and mobility. In 2019, a peer-reviewed pilot study on our treatment method for Frozen Shoulder demonstrated remarkable outcomes after just three sessions:

87%
Increased range of motion by 30°+
52%
Improved by 60° or more
61%
Significantly improved sleep
Frozen Shoulder Study

Real-World Validation

100,000+ Treatments. 81% Five-Star.

The true test of any health intervention is market adoption and customer retention. In Sweden, we have delivered over 100,000 treatments. Out of 1,356 verified reviews, 81% are 5-star ratings.

"I have had problems for almost 10 years and have been to the health center several times, tried chiropractic and massage, but it wasn't until I came to Fasciaklinikerna that I really felt improvement."

— Verified customer, Malmö

100,000+
Treatments delivered
1,356
Verified reviews
81%
Five-star ratings
20+
Clinics in Sweden

The Ecosystem

A Moat of Integration

We do not just sell machines or run clinics. We control the entire value chain of fascia health — creating a flywheel that competitors cannot replicate.

◯

FasciaClinics

Scalable franchise clinic network

High-margin recurring revenue

◈

Atlasbalans

Patented treatment technology

Proprietary hardware moat

◇

Fascia Academy

Education & certification

Quality control pipeline

△

FasciaVibes

Digital community & media

Customer acquisition engine

▽

Fascia Horse

Equine treatment method

Diversified market entry

The Flywheel Effect

Media educates the market→Customers find clinics→Demand for therapists grows→Academy trains therapists→Therapists use our machines→Repeat ∞
The paradigm shift — from clinical to holistic

The Paradigm Shift

The body is not a machine.
It is a living, interconnected ecosystem.

The connective tissue that holds this ecosystem together — the fascia — is emerging as the missing link in understanding physical function, mobility, and pain.

The Business Model

Proven & Profitable

A highly profitable, scalable business model that is ready for international deployment.

Financial Strength

19.3 MSEK

Revenue H1 2025 — 25% year-over-year growth

1,200+

Atlasbalans machines sold globally — 230 in 2025 alone

Positive EBITDA

Profitable before seeking expansion capital — the model works

The Franchise Engine

FasciaClinics operates on a "Treatment in a Box" franchise model. Highly systematized, utilizing automated marketing, standardized treatment protocols, and centralized support.

FasciaClinics interior

Break-even in 1–2 months

Our top-performing franchises reach profitability within 1–2 months of opening. Confirmed across our network.

German Design Award

German Design Award & Good Design Award (USA)

Swedish Fascia World Convention

Swedish Fascia World Convention 2025

The Global Opportunity

Proven in the Hardest Market.
Ready for the World.

Sweden is notoriously one of the most difficult markets in the world to establish new health concepts — highly subsidized, conservative public healthcare. Having built a profitable, rapidly growing network of 20+ clinics in Sweden proves the absolute robustness of our model. If people in Sweden pay out-of-pocket when public healthcare is virtually free, the potential in premium markets is exponential.

Global expansion map
🇺🇸

United States

$12B+ whiplash and chronic pain market

Targeting wellness centers and community health hubs. The US market has the highest out-of-pocket spending on alternative treatments globally.

🇯🇵

Japan

125M people, premium wellness culture

Establishing pilot clinics in Izumo to gather local data before rolling out the franchise model. High willingness to pay and deep cultural alignment with holistic health.

🇩🇪

Germany

Europe's largest wellness market

Strategic partnerships with hotel chains, insurance companies, and corporate wellness programs. Leveraging the German Design Award for brand credibility.

Market Tailwinds

Global Wellness Economy$6.8T → $9.8T by 2029
Non-Opioid Pain Treatment$48B → $96B by 2034
Chronic Pain Population1.5B → Growing annually
FasciaClinics

We are looking for those
who want to build this.

Not those who want a return in three years — but those who want to see a change. We are looking for partners with networks, experience, and the drive to be part of this when it succeeds. Because when it does, it will be profitable for everyone who believed in it early.

Why Sweden is the proof

Sweden is internationally known as the world's hardest market. Spotify was hated. Klarna was despised. ABBA was banned from radio. And yet — they conquered the world. We've been forged in the same fire for 16 years. FasciaClinics hasn't just survived — we've thrived. That's the proof the concept works anywhere.

Request Investor MemorandumSwedish Investor Site →

References

[1] Borsook, D. (2012). A Future Without Chronic Pain: Neuroscience and Clinical Research. Scientific Reports.

[2] Institute of Medicine (2011). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.

[3] Stecco, C., et al. (2018). The fasciocytes: A new cell discovered in the human fascia.

[4] Journal of Case Reports and Studies (2019). Can Myofascial Treatment with Pulsating Vibrations Improve Mobility for Patients with Frozen Shoulder?

[5] Global Wellness Institute (2025). The Global Wellness Economy Hits a Record $6.8 Trillion.

[6] Precedence Research (2024). Non-opioid Pain Treatment Market Size 2025 to 2034.